Pharmaceutical Technology

DECEMBER 5, 2022

Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In the US, the world’s largest pharmaceutical market, most states have legalized cannabinoids for medical use.

Regulation 245

Regulation Drugs Development Marketing 245

Intouch Solutions

NOVEMBER 17, 2021

blue links) of the organic results appeared to be pulling from content outside of the HTML title tag at a much higher frequency. With that, the Intouch SEO team has assessed the impact of these changes across our pharma clients’ brands. Title Tag – This is an HTML element that provides a title for the page. Source: Google.

Marketing 52

Marketing Engineer Branding 52

Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. However, more highly innovative/high-cost treatments, within infectious disease and neurology space, are likely to enter the market for rare disorders, increasing the number of non-oncology RSAs.

Gene Therapy 263

Gene Therapy Marketing Gene Drugs 263

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Drug Delivery 52

Drug Delivery Drugs Manufacturing Marketing 52

XTalks

FEBRUARY 8, 2024

The countdown to Super Bowl LVIII 2024 has begun and businesses across a variety of sectors, including pharma, have snapped up some of the most coveted advertising airtime of the year. This year, Astellas will be repping pharma once again at the Super Bowl with a new TV spot for Veozah (fezolinetant). billion Japanese yen ($8.8

Life Science 105

Life Science Marketing Branding Drugs 105

pharmaphorum

JULY 23, 2019

Customer journeys in pharma are changing, with important implications for the marketing supply chain. How can pharmaceutical marketers capitalise on this trend and free up budget to invest in additional marketing channels? But, as they push the envelope, what are the implications for pharma’s work in customer engagement?

Marketing 52

Marketing Production Development Research 52

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 130

Branding Marketing Pharma Companies Life Science 130

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two

Insulin 96

Insulin Pharmacy Pharma Companies Drugs 96

pharmaphorum

APRIL 26, 2021

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA).

Development 122

Development Medicine Production Marketing 122

pharmaphorum

JANUARY 24, 2022

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise.

Radiology 111

Radiology Marketing Genome Genomics 111

Pharmaceutical Technology

FEBRUARY 22, 2023

The patent battle between Amgen and Sanofi over their cholesterol-lowering antibodies has divided big pharma in the past months. Both drugs come with a high price tag. Amgen won the initial trial in March 2016 and Sanofi faced a potential withdrawal of Praluent from the US market. However, the case was brought back.

Antibody 262

Antibody Drugs Sales Protein 262

XTalks

APRIL 18, 2024

However, Roche has several CSF tests on the market, which include assays in the company’s Elecsys line that are used in conjunction with PET in the diagnosis and monitoring of the disease. There are currently no FDA-authorized blood tests for detecting Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

Intouch Solutions

APRIL 11, 2024

Precision engagement is a data-driven approach developed for marketing and sales needs. In the pharma industry, precision engagement can be used to present patients, healthcare professionals (HCPs), and other stakeholders with relevant information and support at the right time. So, what is precision engagement?

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

pharmaphorum

AUGUST 21, 2022

Auvelity isn’t the first NMDA-targeting antidepressant to reach the market. The biotech hasn’t revealed much information about the reasons for the delay in getting approval, but said in an SEC filing in June this year that it had agreed to “post-marketing commitments” proposed by the FDA, without going into details.

Drugs 98

Drugs FDA Approval Production Marketing 98

World of DTC Marketing

JUNE 23, 2021

Source: Fierce Pharma If that enthusiasm pans out in the long run, it could mean at least 300,000 patients taking the drug, or $10 billion to $15 billion in peak Aduhelm from U.S. Not to mention the $56,000 annual price tag. neurologists or psychiatrists currently treating about 12,000 Alzheimer’s patients.

Drugs 218

Drugs FDA Approval Doctors Doctor 218

pharmaphorum

NOVEMBER 27, 2022

Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. This means batch sizes can be tailored to daily demands rather than market forecasts. Here’s how applying automaton in pharmaceutical labs can help address these.

Production 105

Production Manufacturing Drugs Marketing 105

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Production 264

Production Pharma Production Pharma Companies Drugs 264

pharmaphorum

MARCH 23, 2022

Vyvgart (efgartigimod alfa) became the first drug in the FcRn class to be approved by the FDA last December, and despite a $225,000 annual price tag is predicted to make relatively modest sales in its IV version, which will compete with other IV gMG drugs like AstraZeneca/Alexion’s C5 inhibitor Soliris (eculizumab).

Antibody 52

Antibody Sales FDA Approval Trials 52

Drug Discovery World

MAY 22, 2023

Large pharma involvement in advanced therapies has seen ebbs and flows, with AstraZeneca taking a larger stake in the market and Takeda developing its automation and digital capabilities, but also with GSK letting go of its CGT projects, along with most of the staff involved in its R&D. But are these price tags a barrier to access?

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

pharmaphorum

JANUARY 21, 2022

This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. About the author.

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

MAY 17, 2021

Apellis Pharma has secured FDA approval for its complement C3 inhibitor Empaveli as a treatment for paroxysmal nocturnal hemoglobinuria (PNH) – with a label that will allow it to challenge Alexion’s established therapies directly. . billion and $1.1 billion respectively last year, although Soliris could lose patent protection next year.

Drugs 52

Drugs FDA Approval Marketing Clinical Trials 52

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up. and 17.6%, respectively, according to J&J’s pharma unit Janssen. and 14.1%, respectively.

Trials 52

Trials Sales Drugs Marketing 52

pharmaphorum

MAY 24, 2021

Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who are challenged with increasing demand for more content and creating personalised content to meet the demands of their customers.

Marketing 102

Marketing Branding Sales Life Science 102

pharmaphorum

DECEMBER 2, 2020

Few companies embody the term ‘pharma giant’ as much as Pfizer. This expertise in fermentation and large-scale pharmaceutical production put Pfizer in good stead when in 1941 the US government appealed to the pharma industry for support in producing penicillin for the war effort.

Sales 128

Sales Production Drugs Marketing 128

pharmaphorum

JUNE 2, 2022

Evaluate Pharma’s recent Orphan Drug Report subtitled its overview of the market ‘Niche no longer.’ The report estimates that the orphan drug market will grow twice as fast as the non-orphan market, with a 2021 to 2026 compound annual growth rate of 12%. The price is right. Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

JANUARY 31, 2023

What people did not understand was that “fast tracking” approval does not limit the rigorous process involved in ensuring that a medication or vaccine is safe for market use. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

Delveinsight

FEBRUARY 9, 2021

Breyanzi will come with a price tag of USD 410,300 wholesale price, said the company, justifying it after taking into consideration several factors including medical and clinical value, patient value, and societal value. European Marketing Authorisation to ViiV Healthcare’s Rukobia for Multidrug-resistant HIV.

FDA Approval 52

FDA Approval Marketing Research Protein 52

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S. Oral therapy data presented at ASH.

Development 52

Development Drugs Clinical Development Antibody 52

Intouch Solutions

AUGUST 25, 2021

While this is a big step in the ongoing movement toward protecting consumer privacy, there is increased attention to its impact on email marketing. While this is a step toward placing data control in the hands of the end user, it will require change and innovation in email marketing and the mechanisms by which email is sent to consumers.

Marketing 52

Marketing Regulation Engineer Branding 52

pharmaphorum

NOVEMBER 16, 2022

Of the innovations that have happened recently in pharma drug development, it is cell and gene therapy that have received the most attention. While this is of tremendous benefit to patients, it provides a headache to the pharma industry and to healthcare systems. However, with a price tag of €1.58 At more than $2.1

Gene Therapy 131

Gene Therapy Gene Marketing Development 131

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. Pfizer/BioNTech’s vaccine dominates the market. Together, these mRNA jabs have an iron grip on the covid vaccine market – in the US, they have consolidated a 90% market share. So too are the sales figures. Katrina Megget reports.

Sales 137

Sales Vaccination Vaccine Marketing 137

Pharma Marketing Network

OCTOBER 4, 2020

Don ( PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. He’s a serial entrepreneur, a search engine marketing evangelist and a passionate networker. So I wanted to talk a little bit about that and how are our listeners can leverage the topic you cover in this book for their own marketing efforts.

Doctors 52

Doctors Doctor Marketing Packaging 52

pharmaphorum

AUGUST 26, 2022

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe. million spread over five years.

Gene Therapy 111

Gene Therapy Gene Antibody Marketing 111

Pharmaceutical Technology

JANUARY 27, 2023

The program follows the lead of Pfizer’s warranty programs for Panzyga (immune globulin intravenous) and Xalkori (crizotinib), as pharma continues to explore new types of risk sharing agreements. The drug ranks highly for its cost, with a price of $270,000 before rebates and discounts to treat a typical episode of aTTP.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

pharmaphorum

FEBRUARY 26, 2021

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . Following World War II, Ethicon’s market share in surgical sutures rose from 15% to 70% worldwide.

Sales 126

Sales Production Pharma Companies Marketing 126

XTalks

NOVEMBER 24, 2022

CSL Behring is set to market the drug after having secured global commercialization rights from uniQure for $450 million in 2020. The Hemgenix approval was granted to CSL Behring , a rare disease biotech company based in Pennsylvania, which developed Hemgenix jointly with gene therapy biotech uniQure.

Gene Therapy 52

Gene Therapy Gene FDA Approval Genetics 52

Intouch Solutions

JULY 27, 2021

In the case of aducanumab, it was developed through traditional processes and will be priced traditionally at, as they put it, “whatever the market will bear.” Drug pricing is not going to disappear from legislators’ desks, and even big-business-friendly politicians have pharma in their sights. In the case of the vaccines, the U.S.

Drugs 52

Drugs Marketing Vaccination Vaccine 52